SOLV vs USB · P/E 9.1, rev $8.25B vs P/E 12, rev $28.66B
Solventum Corp. (SOLV) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
SOLV currently screens at market cap $12.91B and trailing P/E 9.1. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the SOLV and USB stock pages for the full models.
Not investment advice.